MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617072729 A) filed by Merck Sharp & Dohme LLC on June 11, 2026, for Agonists Of Trem2 Activity.
Inventors include Anantpur, Manasi; Boyko, Yaroslav; Chen, Joanna, L.; Dimauro, Erin, F.; Henderson, Timothy, J.; Liu, Ping Number; Simov, Vladimir; Vara, Brandon, A.; and Zheng, Xiao, Mei.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present disclosure is directed to compounds of Formula (I) and their use as TREM2 agonists for treatment and prevention of a neurodegenerative disorder associated with a loss of function of human TREM2. The disclosed TREM2 agonists may be useful for the treatment of Alzheimer's Disease and associated neurological conditions.
Disclaimer: Curated by HT Syndication.
